Investment Ideas (38) | Know-how (6) |
MeinIndex products (10) | Theme Investing (25) |
Yield Enhancement (147) |
In about a week, Americans will elect their next president. This will mark the end of an emotional and turbulent election campaign. However, investors would be well advised to keep a cool head and make their investment decisions independently of political considerations. The ZKB Capital Protection Certificate allows you to participate fully in the S&P 500 Index, provided that the knock-out level of 120% is not reached.
The Chinese government is increasing its efforts to tackle the country's economic slowdown. However, initial enthusiasm in financial markets has faded. For investors, the situation opens up investment opportunities.
Luxury seeks to sell exclusivity. At the same time, the industry wants to harness the purchasing power of the masses.
Gold is trading at record highs, defying traditional patterns. What is behind the gold rally and how can investors invest responsibly?
The luxury goods sector experienced a turbulent year. However, the market as a whole is expected to continue growing. The tracker certificate of Zürcher Kantonalbank offers investors wishing to participate in the sector's performance a simple and efficient access.
A dividend strategy can be attractive for investors who want to generate a steady income from their equity exposure. However, a sustainable and reliable distribution policy is key. The tracker certificate from Zürcher Kantonalbank provides simple and efficient access to a global dividend basket.
Global stock markets have had a buoyant start to the year. For investors who want to stay invested in equities while limiting losses, a cushion participation certificate is an attractive option.
The air is getting thinner for US technology titans. After last year's stock price rally, investors expect nothing less than perfection from the «Magnificent Seven», as a review of the quarterly results reveals.
About four months ago, Sandoz was spun off from its parent company Novartis. The success of the Swiss drugmaker is likely to be determined by its performance in the growing biosimilars market.
19.313% p.a. ZKB Barrier Reverse Convertible, 10.01.2025 on worst of LOGN SE/AMS SE 135804789 / CH1358047897 |
ZKB Barrier Reverse Convertible on worst of CrowdStrike Holdings Inc/Snowflake Inc 132911907 / CH1329119072 |
15.6282% p.a. ZKB Barrier Reverse Convertible, 19.02.2025 auf AMS SE 132914049 / CH1329140490 |
16.0994% p.a. ZKB Barrier Reverse Convertible, 19.02.2025 auf AMS SE 135803773 / CH1358037732 |
ZKB Autocallable Reverse Convertible on worst of Adobe Inc/Datadog Inc/Snowflake Inc 132911170 / CH1329111707 |